The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial

Endocrine

Volumn 57, Issue 1, 2017, Pages 51-59

  Salekzamani, Shabnam ^a   Bavil, Abolhassan Shakeri ^b   Mehralizadeh, Hossein ^c   Jafarabadi, Mohammad Asghari ^d,e   Ghezel, Aymaral ^a   Gargari, Bahram Pourghassem ^f  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adhesion molecules; Inflammation; Metabolic syndrome; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 6; PARATHYROID HORMONE; PLACEBO; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; VITAMIN D; 25-HYDROXYVITAMIN D;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; DIAGNOSTIC IMAGING; DIETARY SUPPLEMENT; INFLAMMATION; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; BIOMARKERS; CAROTID INTIMA-MEDIA THICKNESS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; E-SELECTIN; FEMALE; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME; MIDDLE AGED; PARATHYROID HORMONE; TREATMENT OUTCOME; VASCULAR CELL ADHESION MOLECULE-1; VITAMIN D;

EID: 85019259548     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-017-1317-2     Document Type: Article

References (52)

1. K. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith, Harmonizing the metabolic syndrome a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 120, 1640–1645 (2009)
2. E. Kaperonis, C. Liapis, J. Kakisis, D. Dimitroulis, V. Papavassiliou, Inflammation and atherosclerosis. Eur. J. Vasc. Endovasc. Surg. 31, 386–393 (2006)
3. E. Ingelsson, J. Hulthe, L. Lind, Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur. J. Clin. Invest. 38, 502–509 (2008)
4. H. Schuett, M. Luchtefeld, C. Grothusen, K. Grote, B. Schieffer, How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb. Haemost. 102, 215–222 (2009)
5. U.I. Christiana, A.E. Casimir, A.A. Nicholas, M.C. Christian, A.I. Obiefuna, Plasma levels of inflammatory cytokines in adult Nigerians with the metabolic syndrome. Niger. Med. J. 57, 64–68 (2016)
6. T.W. Weiss, H. Arnesen, I. Seljeflot, Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness. Metabolism. 62, 1008–1013 (2013)
7. J.F. Polak, M.J. Pencina, K.M. Pencina, C.J. O’Donnell, P.A. Wolf, R.B. D’Agostino Sr, Carotid-wall intima–media thickness and cardiovascular events. New.Eng. J. Med. 365, 213–221 (2011)
8. P.J. Touboul, D.E. Grobbee, H. den Ruijter, Assessment of subclinical atherosclerosis by carotid intima media thickness: technical issues. Eur. J. Prev. Cardiol 19, 18–24 (2012)
9. A.G. Panayiotou, M. Griffin, P. Kouis, T. Tyllis, N. Georgiou, D. Bond, A.N. Nicolaides, Association between presence of the metabolic syndrome and its components with carotid intima-media thickness and carotid and femoral plaque area: a population study. Diabetol. Metab. Syndr 5, 44–53 (2013)
10. L.H. Li, X.Y. Yin, C.Y. Yao, C.X. Zhu, X.H. Wu, Serum 25-hydroxyvitamin D, parathyroid hormone, and their association with metabolic syndrome in Chinese. Endocrine. 44, 465–472 (2013)
11. C. Gagnon, Z.X. Lu, D.J. Magliano, D.W. Dunstan, J.E. Shaw, P.Z. Zimmet, K. Sikaris, P.R. Ebeling, R.M. Daly, Low Serum 25-Hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J. Clin. Endocrinol. Metab. 97, 1953–1961 (2012)
12. G. Muscogiuri, V. Nuzzo, A. Gatti, A. Zuccoli, S. Savastano, C. Di Somma, R. Pivonello, F. Orio, A. Cola, Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes? Endocrine. 51, 268–273 (2016)
13. S.Y. Ju, H.S. Jeong, D.H. Kim, Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis. J. Clin. Endocrinol. Metab. 17, 1053–1063 (2013)
14. R. Bouillon, L. Verlinden, Does a better vitamin D status help to reduce cardiovascular risks and events. Endocrine. 47, 662–663 (2014)
15. A. Di Nisio, L.D. Toni, E. D’Addato, M.R. Pizzo, P. Sabatino, C. Foresta, 25-Hydroxy vitamin D insufficiency discriminates cardiovascular risk factors accumulation in peri-pubertal boys undergoing overweight screening. Endocrine. 53, 530–537 (2016)
16. G. Sarno, G. Daniele, G. Tirabassi, A.O. Chavez, O.O. Ojo, F. Orio, H. Kahleova, G. Balercia, W.B. Grant, P.D. Rosa, A. Colao, G. Muscogiuri, The impact of vitamin D deficiency on patients ongoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. Endocrine. 50, 568–574 (2015)
17. D. Martins, M. Wolf, D. Pan, A. Zadshir, N. Tareen, R. Thadhani, A. Felsenfeld, B. Levine, R. Mehrotra, K. Norris, Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the third national health and nutrition examination survey. Arch. Intern. Med. 167, 1159–1165 (2007)
18. E. Giovannucci, Y. Liu, B.W. Hollis, E.B. Rimm, 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 168, 1174–1180 (2008)
19. T. Skaaby, L.L.N. Husemoen, C. Pisinger, T. Jørgensen, B.H. Thuesen, M. Fenger, A. Linneberg, Vitamin D status and incident cardiovascular disease and all-cause mortality: a general population study. Endocrine. 43, 618–625 (2013)
20. E. Kassi, C. Adamopoulos, E.K. Basdra, A.G. Papavassiliou, Role of vitamin D in atherosclerosis. Circulation. 128, 2517–2531 (2013)
21. M. Bozic, Á. Álvarez, C. de Pablo, M.D. Sanchez-Niño, A. Ortiz, X. Dolcet, M. Encinas, E. Fernandez, J.M. Valdivielso, Impaired vitamin D signaling in endothelial cell Leads to an enhanced leukocyte-endothelium interplay: implications for atherosclerosis development. PLoS. ONE. 10, e0136863 (2015)
22. H. Dobnig, S. Pilz, H. Scharnagl, W. Renner, U. Seelhorst, B. Wellnitz, J. Kinkeldei, B.O. Boehm, G. Weihrauch, W. Maerz, Independent association of low serum 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 168, 1340–1349 (2008)
23. X. Sun, Z.B. Cao, Y. Zhang, Y. Ishimi, I. Tabata, M. Higuchi, Association between serum 25-hydroxyvitamin D and inflammatory cytokines in healthy adults. Nutrients 6, 221–230 (2014)
24. J. Beilfuss, V. Berg, M. Sneve, R. Jorde, E. Kamycheva, Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine. 60, 870–874 (2012)
25. S.J. Sokol, V. Srinivas, J.P. Crandall, M. Kim, G. Tellides, A.H. Lebastchi, Y. Yu, A.K. Gupta, M.H. Alderman, The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc. Med. 17, 394–404 (2012)
26. G. Targher, L. Bertolini, R. Padovani, L. Zenari, L. Scala, M. Cigolini, G. Arcaro, Serum 25‐hydroxyvitamin D3 concentrations and carotid artery intima‐media thickness among type 2 diabetic patients. Clin. Endocrinol. 65, 593–597 (2006)
27. A.L. Carrelli, M.D. Walker, H. Lowe, D.J. McMahon, T. Rundek, R.L. Sacco, Vitamin D deficiency is associated with subclinical carotid atherosclerosis. The Northern Manhattan study. Stroke. 42, 2240–2245 (2011)
28. V. Carnevale, R. Minonne, A. De Matthaeis, M.A. Annese, P. Tabacco, P. D’Arcangelo, G. D’Amico, A. Scillitani, Carotid intima-media thickness is not associated with vitamin D and PTH levels in patients admitted to an internal medicine department. Endocrine. 47, 833–838 (2014)
29. M. Blondon, M. Sachs, A.N. Hoofnagle, J.H. Ix, E.D. Michos, C. Korcarz, A.D. Gepner, D.S. Siscovick, J.D. Kaufman, J.H. Stei, B. Kestenbaum, I.H. de Boer, 25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 33, 2639–2645 (2013)
30. K.M. Gurses, L. Tokgozoglu, M.U. Yalcin, D. Kocyigit, M. Dural, H. Canpinar, H. Yorgun, M.L. Sahiner, E.B. Kaya, S. Akin, A. Gurlek, D. Guc, K. Aytemir, Markers of subclinical atherosclerosis in premenopausal women with vitamin D deficiency and effect of vitamin D replacement. Atherosclerosis. 237, 784–789 (2014)
31. S. Salekzamani, H. Mehralizadeh, A. Ghezel, Y. Salekzamani, M.A. Jafarabadi, A.S. Bavil, B.P. Gargari, Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial. J. Endocrinol. Invest. 39, 1303–1313 (2016)
32. F. Azizi, F. Hadaegh, D. Khalili, A. Esteghamati, F. Hosseinpanah, A. Delavari, B. Larijani, P. Mirmiran, A. Zabetian, Y. Mehrabi, R. Kelishadi, H. Aghajani, Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch. Iran. Med. 13, 426–428 (2010)
33. M. Saghaei, Random allocation software for parallel group randomized trials. BMC. Med. Res. Methodol. 4, 26–31 (2004)
34. M.F. Holick, N.C. Binkley, H.A. Bischoff-Ferrari, C.M. Gordon, D.A. Hanley, R.P. Heaney, M.H. Murad, C.M. Weaver, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1911–1930 (2011)
35. R.P. Heaney, Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr. Rev. 72, 48–54 (2014)
36. A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton, R.A. Durazo-Arvizu, J.C. Gallagher, R.L. Gallo, G. Jones, C.S. Kovacs, S.T. Mayne, C.J. Rosen, S.A. Shapses, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96, 53–58 (2011)
37. IPAQ Research Committee, Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ)–short and long forms. Retrieved September 17, 2008 (2005)
38. C.L. Craig, A.L. Marshall, M. Sjostrom, A.E. Bauman, M.L. Booth, B.E. Ainsworth, M. Pratt, U. Ekelund, A. Yngve, J.F. Sallis, P. Oja, International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports. Exerc. 195, 3508–1381 (2003)
39. A.G. Pittas, S.S. Harris, P.C. Stark, B. Dawson-Haghes, the effects of calcium and vitamin D supplementation on blood glugose and markers of inflammation in nondiabetic adults. Diabetes. Care. 30, 980–986 (2007)
40. M. Kim, W. Na, C. Sohn, Correlation between vitamin D and cardiovascular disease predictors in overweight and obese Koreans. J. Clin. Biochem. Nutr. 52, 167–171 (2013)
41. S. Shab‐Bidar, T.R. Neyestani, A. Djazayery, M.R. Eshragian, A. Houshiarrad, A. Kalayi, N. Shariatzadeh, N. Khalaji, A. Garavi, Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes. Metab. Res. Rev. 28, 424–430 (2012)
42. R. Jorde, M. Sneve, P.A. Torjesen, Y. Figenschau, L.G. Gøransson, R. Omdal, No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine. 50, 175–180 (2010)
43. P.D. Chandler, J.B. Scott, B.F. Drake, K. Ng, J.E. Manson, N. Rifai, A.T. Chan, G.G. Bennett, B.W. Hollis, E.L. Giovanucci, K.M. Emmons, C.S. Fuch, Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial. Cancer. Prev. Res 7, 218–225 (2014)
44. M. Gannage-Yared, M. Azoury, I. Mansour, R. Baddoura, G. Halaby, R. Naaman, Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women. J. Endocrinol. Invest. 26, 748–753 (2003)
45. M. Rohla, T. Weiss, Metabolic syndrome, inflammation and atherothrombosis. Hämostaseologie 33, 283–294 (2013)
46. P.M. Ridker, N. Rifai, M.J. Stampfer, C.H. Hennekens, Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 101, 1767–1772 (2000)
47. C. Langenberg, J. Bergstrom, C. Scheidt-Nave, J. Pfleischifter, E. Barret-Connor, Cardiovascular death and the metabolic syndrome–role of adiposity-signaling hormones and inflammatory markers. Diabetes. Care. 29, 1363–9136 (2006)
48. C.M. Matter, C. Handschin, RANTES (regulated on activation, normal T cell expressed and secreted), inflammation, obesity, and the metabolic syndrome. Circulation. 115, 946–948 (2007)
49. M.M. Assimon, P.V. Salenger, H.A. EL‐Fawal, D.L. Mason, Nutritional vitamin D supplementation in haemodialysis: a potential vascular benefit? Nephrology. 17, 237–242 (2012)
50. K. Kudo, S. Hasegawa, Y. Suzuki et al., 1α, 25-Dihydroxyvitamin D 3 inhibits vascular cellular adhesion molecule-1 expression and interleukin-8 production in human coronary arterial endothelial cells. J. Steroid. Biochem. Mol. Biol. 132, 290–294 (2012)
51. M. Kocijancic, Z. Cubranic, B. Vujicic, S. Racki, S. Dvornik, L. Zaputovic, Soluble intracellular adhesion molecule-1 and omentin-1 as potential biomarkers of subclinical atherosclerosis in hemodialysis patients. Int. Urol. Nephrol. 48, 1145–1154 (2016)
52. M. Aviram, M. Rosenblat, D. Gaitini, S. Nitecki, A. Hoffman, L. Dornfeld, N. Volkova, D. Presser, J. Attias, H. Liker, T. Hayek, Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin. Nutr. 23, 423–433 (2004)